Ganciclovir
1 NDC across 1 manufacturer|0 Generic,1 Brand
Ganciclovir is used to treat aids-related opportunistic infections and cytomegalovirus retinitis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Dec 22, 1994, and the first generic was approved Jun 27, 2003. In 2024, Medicare Part D spent $9 million on Ganciclovir across 19,000 claims for 11,000 beneficiaries.
Ganciclovir is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $91.24 to $91.24 per GM. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$91.24 – $91.24
per GM
7d Activity
avg -0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Bausch & Lomb Incorporated manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing GANCICLOVIR
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ZIRGAN 0.15% OPHTHALMIC GEL | $91.2411 per GM | -0.02% |
Frequently Asked Questions
What is Ganciclovir used to treat?
Ganciclovir is used to treat aids-related opportunistic infections and cytomegalovirus retinitis, per the National Library of Medicine's MED-RT classification.
When did Ganciclovir become available as a generic?
FDA approved the first generic Ganciclovir (ANDA) on Jun 27, 2003.
How much does Medicare spend on Ganciclovir?
In 2024, Medicare Part D spent $9 million on Ganciclovir across 19,000 claims for 11,000 beneficiaries.
How many Ganciclovir products are on the market?
The Ganciclovir drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Ganciclovir?
NADAC reference prices for Ganciclovir range from $91.2411 to $91.2411 per GM.
Which manufacturers make Ganciclovir?
1 manufacturer lists Ganciclovir in NADAC. Ranked by number of NDCs, the largest are Bausch & Lomb Incorporated (1).
How has the price of Ganciclovir changed recently?
Over the past 7 days, 0 Ganciclovir NDCs rose and 2 fell, with a market-wide average change of -0.0%.